NEWS BYTES
Pfizer launches PCV20 in India to protect adults against pneumococcal disease
With broader serotype coverage, Pfizer’ s vaccine marks a significant advancement in protection against pneumococcal disease in adults.
Indian scientists spot‘ Troublemaker’ immune cells driving inflammation
Scientists from CSIR-CDRI, Lucknow, have reported a significant finding that could help in the development of new treatments for chronic inflammation.
SCHOTT sets new highs in primary pharma packaging
The global pioneer in specialty glass has added syringe and cartridge glass tubing to its existing state-of-the-art manufacturing capabilities in Gujarat.
Thermo Fisher Scientific announces crucial investments in India
The announcements came when senior executives addressed government, industry and academia at the Biopharma Conclave 2025.
08
BioVoiceNews | September 2025